Laboratoire de recherche NAFLD et résistance à l'insuline

Titre
Secrétariat d'endocrinologie et diabétologie
Adresse

Rue Gabrielle Perret-Gentil 4
1205 Genève
Suisse

Complément d'adresse
Bâtiment Klein, 1er étage
Titre
Secrétariat de l'unité de nutrition
Adresse

Boulevard de la Cluse 87
1205 Genève
Suisse

Titre
Secrétariat de l'unité d'éducation thérapeutique
Adresse

Chemin Venel 7
Villa Soleillane
1206 Genève
Suisse

Titre
Secrétariat de lipidologie
Adresse

Rue Gabrielle Perret-Gentil 4
1205 Genève
Suisse

Pr François Jornayvaz
Professeur
François Jornayvaz
Médecin-chef de service

Responsable : Pr François JORNAYVAZ

Groupe de recherche

  • Dr Emmanuel SOMM, biologiste, collaborateur scientifique 
  • Mme Elodie PERROUD, laborantine 
  • Dr Karim GARIANI, Privat-Docent, médecin adjoint agrégé 

Our lab is mainly focused on the link between nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) and insulin resistance, which represents a key step in the development of type 2 diabetes. The topic is of importance and clinically relevant since type 2 diabetes is projected to increase and affect 592 million people worldwide by 2035. NAFLD/NASH is a very important disease and now represents the most frequent chronic liver disease worldwide. It is estimated to affect up to 60 to 70% of people with type 2 diabetes. Moreover, NAFLD represents the hepatic manifestation of the metabolic syndrome and as such represents a cardiovascular risk factor. The aims of the lab are therefore to: identify patients with NAFLD; identify which patients will present progression of their hepatic disease; and find therapeutic targets to prevent and heal NAFLD/NASH. To these ends, we use a translational approach using cell cultures, in vivo animal models and humans.

Groupe de recherche

Consultez le biosketch et les publications

Dernière mise à jour : 17/12/2021